In the examination of the expression patterns of prognostic genes during disease progression, upregulation of EPHB2 and FCN3 as well as downregulation of TINAG were found in patients with CRC, demonstrating the trend of prognostic gene expression over the course of CRC (Figure 6I). This evidence concerns the gene EPHB2 and colorectal carcinoma.